Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Financial advice can be crucial for young adults facing various financial challenges. Discover the benefits of seeking expert guidance.
25,240 articlesSarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Disney's stock is under renewed pressure as its core businesses face slower growth. The market is awaiting clearer pr...
A prominent crypto trader files a lawsuit against Coinbase claiming it refused to return DAI funds stolen in a phishi...
NVIDIA is piloting residential micro data centers in new homes, pairing Span panels with PulteGroup builds to tap gri...
At a Miami conference this week, Tom Lee floated a $22,000 Ethereum target, tying it to a mix of Bitcoin price milest...
President Trump nominates Cameron Hamilton to run FEMA, marking a surprising return to a central agency as disaster r...
Fraudsters are targeting XRPL users with fake airdrops and impersonation schemes as activity climbs. A ripple insider...
The Kiplinger Letter argues that most GDP growth celebrated in Washington isn’t driven by AI, a claim with sharp impl...
Guggenheim started coverage on StubHub with a Buy rating and a $12.50 price target, signaling optimism for the live-e...
NVIDIA faces a supply bottleneck at its chipmaker that could cap near-term revenue even as AI demand remains strong. ...
A new AI platform launch aims to empower independent brokerages to stay independent, compete scale, and win at scale ...
The trillion-dollar club has swelled to 14 as of late May 2026, led by AI-enabled tech giants. The combined market ca...